Fluzopari
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Fluzopari, covering 2022-10-28 to 2022-10-28. Get the full timeline:
Most recent: Clinical Trial Update: Fluzopari Combined With Apatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer [Phase 2]